HomeMNPR • NASDAQ
add
Monopar Therapeutics Inc
Previous close
$54.79
Day range
$53.24 - $58.22
Year range
$26.06 - $105.00
Market cap
370.68M USD
Avg Volume
188.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.16M | -44.42% |
Net income | -5.20M | 52.40% |
Net profit margin | — | — |
Earnings per share | -0.61 | 77.82% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 140.40M | 133.17% |
Total assets | 140.72M | 133.40% |
Total liabilities | 2.89M | -44.99% |
Total equity | 137.83M | — |
Shares outstanding | 6.69M | — |
Price to book | 2.66 | — |
Return on assets | -10.80% | — |
Return on capital | -11.01% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.20M | 52.40% |
Cash from operations | -3.37M | -68.64% |
Cash from investing | -62.19M | -333.72% |
Cash from financing | -384.68K | -100.69% |
Net change in cash | -65.84M | -265.45% |
Free cash flow | -7.03M | -176.74% |
About
Founded
2014
Headquarters
Website
Employees
22
